Becker's Healthcare August 1, 2024
EncircleRx, a program helping employers control the cost of GLP-1 drugs for weight-loss, has reached 2 million enrollees in its first six months.
Cigna launched the program in March, which it called the “first-ever” GLP-1 management program with a financial guarantee for health plans.
GLP-1 medications approved for weight loss include Wegovy, Saxenda and Zepbound. These drugs can cost upward of $1,000 a month. On an Aug. 1 call with investors, Cigna CEO David Cordani said GLP-1s are expected to be the No.1 driver of pharmacy benefit trends for plans of all sizes in 2024.
Eric Palmer,...
Today's Sponsors
Today's Sponsor